ORKA - Latest News

Oruka Therapeutics, Inc. (ORKA), operates in Healthcare / Biotechnology, trades on NASDAQ.

Market capitalization stands near $4.72B. Beta to the broader market is -0.39.

The article list below shows the most recent ORKA headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent ORKA Headlines

ORKA Stock Down 5% Despite Positive Week 28 Psoriasis Efficacy Data

zacks.com - Sep 24, 2026

Oruka's ORKA-001 delivers deeper psoriasis clearance at week 28, but safety disclosures may have weighed on shares despite positive efficacy data.

Oruka Therapeutics Says Psoriasis Drug Shows Deepening Efficacy

benzinga.com - Sep 23, 2026

Oruka Therapeutics Inc. (NASDAQ:ORKA) on Wednesday reported positive week 28 outcomes from its Phase 2a clinical trial evaluating ORKA-001 for modera

Oruka Therapeutics Announces Positive Week 28 Data for ORKA-001 from the Ongoing EVERLAST-A Trial Showing Deepening of Responses Without Additional Dosing

globenewswire.com - Sep 23, 2026

PASI 100 increased to 71. 4% and PASI 90 increased to 87.

Oruka Therapeutics to Attend the 2026 Morgan Stanley Global Healthcare Conference

globenewswire.com - Sep 9, 2026

MENLO PARK, Calif. , Sept.

ORKA Stock Up More Than 60% in 3 Months: Here's What You Should Know

zacks.com - Aug 28, 2026

Oruka's three-month rally reflects investor confidence in ORKA-001, with key clinical data and pipeline milestones scheduled ahead.

How News Affects ORKA Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track ORKA's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked ORKA news questions

What is the latest ORKA news headline?

The most recent ORKA headline (Sep 24, 2026) is "ORKA Stock Down 5% Despite Positive Week 28 Psoriasis Efficacy Data". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.

How fresh is the ORKA news on this page?

News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.

What ORKA news moves options pricing?

Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.

How can I track unusual ORKA options activity related to news?

Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.